Trial Profile
A multi-center, randomized, double-blind, double-dummy study evaluating the safety and efficacy of the addition of amlodipine to quinapril or losartan in the treatment of diabetic hypertensive subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2021
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Quinapril (Primary) ; Losartan
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Acronyms ADHERE
- Sponsors Pfizer; Viatris Inc
- 07 Oct 2008 Results have been published in Annals of Pharmacotherapy.
- 06 Oct 2008 Primary endpoint 'target blood pressure achievement rate' has been met.
- 29 Aug 2006 Status change